Loading...
DOCUMENTS
98
NOTICES
156
MOTS CLES
Biologic drug
Sipuleucel-T
Autoimmune diseases
Apremilast
Adolescent
Pharmacoepidemiology
Sacroiliitis
Ustekinumab
Biological Therapy
Alitretinoin
Access to care
Vigibase®
Antimicrobial Stewardship
Adverse side effects
Biosimilar Pharmaceuticals
COVID-19
Biologic therapy
Aging
Immunotherapy
Cardio-oncology
BTK protein
Bacterial rhinosinusitis
Biological therapy
ASDAS
Autoimmunity
Dermatology
Pharmaco-Épidémiologie
Atrial fibrillation
Antibiotic misuse
Pharmacovigilance
Atopic dermatitis
Immune checkpoint inhibitors
Acute Myeloid Leukaemia AML
Immune-related adverse events
Glucocorticoids
Amyloidosis
Arthritis
Abus d'antibiotiques
Accelerometer
Antimicrobiens
Systematic review
Addiction
Ankylosing
Anxiety
Anti-HCV Direct Acting Antivirals DAA
Anti-TNF
Placebo
Angiotensin receptor blockers
ArtThese
Azathioprine
Antibiotics
Quality of life
Apre-milast
Anxiété
Auto-Diagnostic
Primary adrenal insufficiency
Epidemiology
Network meta-analysis
Ethics
Auto-immune hepatitis
Alcohol
Cardiotoxicity
Arrhythmia
Intensive care
Burden
Albinism
Axial spondyloarthritis
Bacterial
Spondylitis
Anti-Bacterial Agents
Psoriatic arthritis
Cancer
Antimicrobial resistance
Biologic
Management
Etanercept
Angiotensin-converting enzyme inhibitors
Graft-versus-host disease
Antibiotic resistance
Biomédicaments
Treatment
Meta-Analysis
Pregnancy
Psoriasis
Drug reaction
Infliximab
Spondyloarthritis
Ankylosing spondylitis
Biomarkers
Beta-lactam antibiotics
Biologics
Anticancer drugs
Antimicrobials
Endocrine toxicity
Méta-Analyse
Prostate cancer
Cardiomyopathy
Drug survival
Stability
Adalimumab
Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379 | |
---|---|
Adresse |
Université Paris-Est Créteil Val de Marne (UPEC) Campus Centre de Créteil |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Émilie SBIDIAN |
Axe(s) de recherche
|
|
COLLABORATIONS
|